LYTIR

Insider · SEC Form 4 · Chief Business Officer

Goodman Noah

In the 12 months to Nov 8, 2026, on the open market: sold $1.2M of KYMR. Filed a median of 0 business days after the trade.

Open-market purchases and sales this filer reported on SEC Form 4, by the day traded. Insiders have two business days to file. A sale marked 10b5-1 was made under a plan adopted in advance. How to read these

Insider purchases and sales, by month (last 12 months)Insider purchases: $0 in total; Insider sales: $1.2M in total.Jun: Insider sales $818KJul: Insider sales $387KDecJanFebMarAprMayJunJulAugSepOctNov
Insider purchases above the line: $0Insider sales below: $1.2M
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.
  1. KYMRSold: Kymera Therapeutics, Inc. Jul 1, 2026 3,389 shares filed Jul 2, 2026 47,179 shares held directly after, as filed 10b5-1 plan filing $387K
  2. KYMRSold: Kymera Therapeutics, Inc. Jun 25, 2026 5,000 shares filed Jun 25, 2026 2 transactions 10b5-1 plan filing $570K
  3. KYMRSold: Kymera Therapeutics, Inc. Jun 22, 2026 2,500 shares filed Jun 22, 2026 50,195 shares held directly after, as filed 10b5-1 plan filing $248K

Source: SEC Form 4 filings. Value is shares × the price reported on the filing; a filing whose price failed Lytir's check against the market price is left out, and a trade that related owners reported on separate forms is counted once. Filings can be late, amended or wrong at the source; see methodology.

Other Form 4 entries

Not counted above: entries this filer reported on Form 4 in the same 12 months that are not open-market purchases or sales. Each entry is one line of a filing.

  • KYMR: option exercise or conversion (code M), 2 entries, Jun 22 to Jun 25, 2026
Code M
An exercise or conversion of a derivative security received from the company, such as stock options.

Source: the same SEC Form 4 filings. The codes are the SEC's own transaction codes; the meanings above are a plain-words reading of the SEC's Form 4 instructions.